CRVS R&D Expense Growth
Corvus Pharmaceuticals Inc · R&D Expense Growth
CRVS R&D Expense Growth
Latest reported73.94%period ending
CRVS FY R&D Growth (YoY) (0.00% → 73.94%)
Latest values, visible window
High-resolution chart · PNG
CRVS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 73.9438% | |
| 17.3% | |
| -32.4587% | |
| -15.9608% | |
| -8.5297% | |
| -16.1817% | |
| -1.5835% | |
| -16.6699% | |
| 57.7361% | |
| 158.5976% | |
| 27,283.9103% | |
| 0% |